The Pharma Industry Review website upholds the highest standards of ethical and professional journalism.
The quality and trustworthiness of the information we provide to readers is paramount to the success of our business. In our industry news coverage, we seek to be independent, fair and accurate.
Most of our analysis and comments are provided by industry experts. Any comment is clearly labelled as such.
Our mission is to provide a news and information platform for the pharmaceutical industry which helps our readers to make better informed decisions for their businesses and themselves.
We are a global website and our focus is international, but as we are headquartered in London our house style is ordinarily UK English spelling and grammar.
We make every effort to verify and check the information we publish. If you spot a mistake, or would like to make a complaint about our coverage, please contact email@example.com. All mistakes will be corrected as soon as possible.
Any content paid for by an advertiser is clearly labelled as such using words such as “sponsored”, “advertising” or “advertorial”. Content which is editorially independent but created with the help of specific funding from an advertiser may be presented with the words “in association with” or “supported by”.
Information that has not been independently verified should be attributed to the source it has been taken from. Quotes which we have not personally gathered should be attributed to a source.
It is forbidden for our editors or journalists to copy information from other sources without attribution.
Our editors and journalists are required to follow the standards laid out in the UK Editors’ Code with specific attention to the clauses on Financial Journalism:
• Journalists must not use for their own profit financial information they receive in advance of its general publication, nor should they pass such information to others
• They must not write about shares or securities in whose performance they know that they or their close families have a significant financial interest without disclosing the interest to the editor or financial editor.
• They must not buy or sell, either directly or through nominees or agents, shares or securities about which they have written recently or about which they intend to write in the near future.
Stories are never sent to sources in advance of publication. Journalists may, however, choose to provide a copy of direct quotes with a source in advance of publication to check for accuracy.
Named sources are preferable to anonymous ones, but there may be occasions where we publish information from unnamed sources, provided we are satisfied that they have a good reason to remain anonymous and are providing us with high-quality information.
Our journalists have a duty to protect confidential sources.